Cancer mortality numbers increased during the COVID-19 pandemic, due to insufficient doctor–patient communication.
Doping and sports: the topic is always relevant when major international competitions, like the Olympic Games, are taking place.
An ongoing European study aims to assess the knowledge and perceptions of health professionals regarding medical cannabis.
"No one has impacted the very nature of medical marketing more than the multi-talented Dr. Arthur Sackler," says the Medical Advertising Hall of Fame about the man whose family name is now synonymous with the opioid epidemic.
Particle therapy fights with a prescribed high load and extreme precision against radioresistant tumors, while preserving healthy tissue.
2031. Catherine has a chronic illness. AI and digital interventions shape her care through diagnosis, psychological support, therapeutic guidance, and medication.
When physicians present to a colleague as a patient, should they disclose their profession? Are there subjective preferences, or an ethical duty to do so?
APAAACI´s recent white paper showed that various air pollutants threaten human respiratory and cardiovascular health
The APAAACI Task Force on COVID-19 recognized most common atopic conditions and skin allergies in healthcare workers during the pandemic.
Young physicians in Brazil and Ireland are struggling with anxiety disorder even months after working in clinical practice during the pandemic.
During pregnancy, women are not only at high risk for severe progression of the disease, they also face an increased risk of premature births and stillbirths.
In pathology, the protein Ki-67 is used to analyse conspicuous tissue changes. Researchers have discovered how this helpful protein is formed.
Compelling evidence suggests that many MS cases could be prevented by stopping EBV infection.
In 17% of patients with immune-mediated inflammatory diseases (IMID) on immunomodulating treatment, no seroconversion occurred after their first dose of SARS-CoV-2 vaccination.
The systemic immune-inflammation (SII) index emerged as a novel biomarker associated with a worse prognosis in different diseases.
Non-biologic systemic treatment more than doubled the risk for hospitalisation and death compared with tumour necrosis factor (TNF) inhibition.
Inhibition of heat shock protein 90 (HSP90) may be an interesting novel treatment mode for psoriasis. In a proof-of-concept trial, therapy with RGRN-305 showed marked efficacy with an acceptable safety profile.
Gene profiles for active psoriatic arthritis patients compared with healthy controls showed that genes related to neutrophils, monocytes, eosinophils, and macrophages are upregulated.
In a comparison of 5 commonly used systemic treatments for psoriasis, guselkumab demonstrated the highest drug survival and adalimumab the lowest at 1 and 2 years.
Psoriasis patients' microbiota are less diverse and have a decreased functional richness compared to healthy controls. Differences occured also in similar lifestyles of psoriasis patients and partners.